Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRIN
5526
DELISTED
Marin Software
MRIN
| $341K | ﹤0.01% |
1,206
-157
| -12% | -$42.6K |
|
5527
NewtekOne
NEWT
$423M
| $341K | ﹤0.01% |
+19,223
| New | +$338K |
|
5528
CALL
Oceaneering
OII
$4.74B
| $340K | ﹤0.01% |
7,300
+2,600
| +55% | +$137K |
|
5529
BlackRock TCP Capital
TCPC
$273M
| $340K | ﹤0.01% |
22,249
-15,387
| -41% | -$245K |
|
|
NWY
5530
DELISTED
New York & Co Inc
NWY
| $340K | ﹤0.01% |
126,942
+107,055
| +538% | +$275K |
|
|
HNR
5531
DELISTED
Harvest Natural Resources
HNR
| $340K | ﹤0.01% |
48,557
+6,912
| +17% | +$33.6K |
|
|
EXXI
5532
PUT
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $340K | ﹤0.01% |
129,400
+89,000
| +220% | +$328K |
|
5533
CALL
Clean Energy Fuels
CLNE
$425M
| $339K | ﹤0.01% |
60,400
-12,300
| -17% | -$92.3K |
|
5534
Protolabs
PRLB
$1.79B
| $339K | ﹤0.01% |
5,027
-743
| -13% | -$52.4K |
|
|
PWOD
5535
DELISTED
Penns Woods Bancorp
PWOD
| $339K | ﹤0.01% |
11,529
+3,289
| +40% | +$96.4K |
|
5536
CALL
Axos Financial
AX
$5.6B
| $338K | ﹤0.01% |
12,800
-400
| -3% | -$9.51K |
|
5537
Agilysys
AGYS
$3.04B
| $337K | ﹤0.01% |
36,712
-18,464
| -33% | -$177K |
|
5538
Cohen & Steers Infrastructure Fund
UTF
$3.11B
| $337K | ﹤0.01% |
16,030
-67,597
| -81% | -$1.52M |
|
|
ACTA
5539
DELISTED
Actua Corp
ACTA
| $337K | ﹤0.01% |
23,604
+5,053
| +27% | +$70.3K |
|
5540
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.26B
| $336K | ﹤0.01% |
+29,533
| New | +$340K |
|
|
ECHO
5541
DELISTED
Echo Global Logistics, Inc.
ECHO
| $336K | ﹤0.01% |
10,276
-82,804
| -89% | -$2.51M |
|
|
AT
5542
DELISTED
Atlantic Power Corporation
AT
| $336K | ﹤0.01% |
108,830
-20,429
| -16% | -$62.2K |
|
5543
Lantheus
LNTH
$6.58B
| $335K | ﹤0.01% |
+54,167
| New | +$346K |
|
|
ICD
5544
DELISTED
Independence Contract Drilling, Inc.
ICD
| $335K | ﹤0.01% |
1,889
-2,402
| -56% | -$376K |
|
|
PBFX
5545
CALL
DELISTED
PBF LOGISTICS LP
PBFX
| $335K | ﹤0.01% |
+14,000
| New | +$331K |
|
|
IMMU
5546
CALL
DELISTED
Immunomedics Inc
IMMU
| $335K | ﹤0.01% |
82,400
-120,100
| -59% | -$491K |
|
|
BNK
5547
DELISTED
C1 FINL INC COM STK (FL)
BNK
| $335K | ﹤0.01% |
17,269
-731
| -4% | -$13.6K |
|
|
WRES
5548
DELISTED
WARREN RESOURCES INC
WRES
| $334K | ﹤0.01% |
725,596
+287,335
| +66% | +$247K |
|
5549
Vera Bradley
VRA
$99.2M
| $330K | ﹤0.01% |
29,295
-4,225
| -13% | -$57.2K |
|
|
DRNA
5550
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $330K | ﹤0.01% |
+23,634
| New | +$433K |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.